A look back at #ACR22 Day 1. https://t.co/UIZnquWAiU https://t.co/EZ2su56J5H

FDA is investigating risk of severe hypocalcemia in dialysis patients taking Prolia (denosumab). After an interim safety data review reports of hypocalcemia w/ advanced CKD. Monitor Ca, use Ca & vit D supplements. Await further FDA information https://t.co/6pMwBPFJJr https://t.co/lTdpX0FQwj

Do oral JAKs in atopic dermatitis cause VTE? Meta-analysis (15 RCTs, 466 993 pts) does NOT show increased risk of VTE associated with AD & JAK inhibitors (HR 0.95) w/ low VTE incidence (0.05%) w/ JAKi and (0.03%) placebo. https://t.co/vcvW8N11cm https://t.co/N5zx0I0lrn

Where are we with treating Pre-Rheumatoid Arthritis? Dr. Richard Conway ( @RichardPAConway ) discusses abstracts #0530, #1603 and #1604 shared at #ACR22. https://t.co/AagsZCyhSE https://t.co/K1RvdOMzvf

Spondyloarthritis Topic Panel - #ACR22 SpA Panelists: Drs. Lianne Gensler, Antoni Chan, Akhil Sood, Eric Dein, Sheila Reyes, Catherine Sims @synovialjoints @AkhilSoodMD @ericdeinmd @RHEUMarampa @DrCassySims https://t.co/uFPW3NxZEm https://t.co/stjmhcFoaS

Women vs. Men: Response to Treatment in Seronegative Arthritis Dr. Janet Pope ( @Janetbirdope) discusses abstracts 1614 and 1601 at #ACR22 https://t.co/nUFjPr1Zya https://t.co/L47pzS7YXv

Treatment Considerations in Axial Spondyloarthritis Dr. Lianne Gensler discusses treatment considerations in Axial SpA from #ACR22. -Abstract 0402 -Abstract 0388 -Abstract 0544 -Abstract 0545 https://t.co/1PvN3SnqHQ https://t.co/i2nyvjyv3D

Updates on Reproductive Health in Women with SLE Dr. Catherine Sims ( @DrCassySims) summarizes reproductive health abstracts presented at #ACR22. https://t.co/QxzoBWMexo https://t.co/4wUPKOOemE

Differences in Presentation and Outcomes of Early vs Late Onset PsA Dr. Petryna ( @DrPetryna) discusses abstract 0377 presented at #ACR22. Abstract 0377: Differences in Early-onset vs. Late-onset PsA: Data from the RESPONDIA and REGISPONSER Studies https://t.co/3dwYmx7Hva https://t.co/ZFlFmWRbMK

Potential new treatment for Sjogren's Is there finally something new on the horizon in Sjogren’s syndrome? Dr. Eric Dein. ( @ericdeinmd) discusses studies presented at #ACR22. https://t.co/YinEPKlJb2 https://t.co/YOsc159GFt

Best of #ACR22 Day 2 in PSA -Efficacy and Safety Results from BE OPTIMAL in PsA -JAK inhibitors in rheumatic diseases -Who is the Winner? Switch vs Cycle in PsA -Women vs. Men: Response to Treatment in Seronegative Arthritis and more. https://t.co/JSKafxioMT https://t.co/Ov0VuCdX5y

Topic Podcasts - PsA Part1 Best of PsA on Day 1 #ACR22 https://t.co/uXxUwy6u9G https://t.co/GDDXgcn2EC